Spaulding Clinical: Neal Collins, medical director
Spaulding Clinical has hired Neal Collins as medical director. Collins—whose experience includes serving in senior positions at Merck, AstraZeneca and Pfizer—will lead medical staff and oversee Phase I studies from the firm’s Spaulding’s West Bend, Wis., clinical pharmacology unit.
Spaulding Clinical CEO Cassandra Erato said, “As a leader in Phase I-IV clinical trials oversight as well as regulatory alignment and strategy, his wealth of experience in both global and U.S. markets makes him a valuable addition. His broad therapeutic expertise — spanning oncology, internal medicine, primary care, infectious disease, vaccines, women’s health and endocrinology — will be especially valuable during this time of growth for Spaulding.”
